NCT02056158View on ClinicalTrials.gov

HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 13, 2014

Primary Completion Date

October 5, 2015

Study Completion Date

October 23, 2015

Conditions
HIVCOPDEmphysemaSmoking
Trial Locations (1)

10021

Department of Genetic Medicne, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT02056158 - HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium | Biotech Hunter | Biotech Hunter